This information is generalized and not intended as specific medical advice. Consult your healthcare professional before taking or discontinuing any drug or commencing any course of treatment. Serious ...
(RTTNews) - Eli Lilly and Company (LLY) on Monday said its new formulation of Taltz (ixekizumab), which was approved by the FDA in May this year, is being made available across the U.S. The company ...
--Eli Lilly and Company today announced positive topline results from the novel TOGETHER-PsA open-label Phase 3 b trial evaluating the concomitant use of Taltz and Zepbound compared to Taltz alone in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results